A prodrug conjugate between photosensitizer molecules and anticancer drug molecules with the caspase 3-cleavable peptide linker, Asp–Glu–Val–Asp (DEVD), was designed for targeted cancer therapy [84]. Here, CASP3 is linked to cancer.